Dabur Invests ₹60 Crore to Acquire Minority Stake in RAS Beauty
Dabur India Limited will invest ₹60 crore in RAS Beauty Private Limited, a luxury skincare D2C company, to acquire a minority stake. The investment, made through Dabur Ventures, aims to support RAS Beauty's growth and expansion. RAS Beauty, founded by Shubhika Jain, Suramya Jain, and Sangeeta Jain, has a 3-year CAGR of around 75% with an ARR of approximately ₹100 Crore. The deal was announced on March 2, 2026.
The investment of ₹60 crore is significant and is likely to have a moderate impact on Dabur's portfolio and RAS Beauty's growth.
The announcement highlights a strategic investment by Dabur in a high-growth company, indicating positive future prospects and expansion.
Dabur India Limited has announced an investment in RAS Beauty Private Limited, a luxury skincare D2C company, through its Dabur Ventures initiative. The agreement, signed on March 2, 2026, involves Dabur acquiring a minority stake in the Raipur-based company for ₹60 crore. RAS Beauty, founded by Shubhika Jain, Suramya Jain, and Sangeeta Jain, specializes in natural beauty products, including face elixirs, serums, and moisturizers. The company has demonstrated a 3-year CAGR of around 75% with an ARR of approximately ₹100 Crore and high gross margin.
Mr. Abhinav Dhall, Executive Director – Group Head Corporate Strategy at Dabur India Ltd, expressed enthusiasm for RAS Beauty's distinct skincare value proposition and its potential in the premium beauty segment. Ms. Shubhika Jain, co-founder and CEO of RAS Beauty Private Limited, highlighted the inspiration drawn from Dabur's legacy and the investment's role in accelerating omnichannel presence and R&D capabilities. Dabur Ventures, launched in October 2025 with a capital allocation of ₹500 Crore, aims to support progressive ventures in personal care, healthcare, wellness foods, beverages, and Ayurveda.
What to do with a filing like this
Dabur India Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dabur India Limited. Read the original for the full detail.